Evidence map›Paper›PMID 17695254›Full record

ArticleBioTechniques2007

Concomitant quantification of targeted drug delivery and biological response in individual cells.

Massimo Pinto, Roger W Howell

Open access · goldAbstract read
In one paragraph

Article in BioTechniques, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lognormal distribution of cellular uptake of radioactivity: statistical analysis of alpha-particle track autoradiography.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2008
    Article
  10. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Massimo PintoUniversity of Medicine and Dentistry of New Jersey, Newark, NJ 07101, USA.
Roger W Howell
University Hospital, Newark · US

Funding

EFFECTS OF NONUNIFORM DISTRIBUTIONS OF RADIOACTIVITYR01CA083838 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HOWELL, ROGER W. · 2000 to 2009
$2.2M
UPGRADES FOR FLOW CYTOMETRY: MULTI PARAMETER ANALYSISS10RR014753 · NCRR · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DENNY, THOMAS N · 2000 to 2000
$340k
NCI NIH HHS R01 CA083838NCI NIH HHS R01CA83838NCRR NIH HHS 1 S10 RR14753-01
6 · The paper itself

Abstract

Targeted therapies result in heterogeneous drug delivery, often with highly variable drug uptake in the targeted cells and significant numbers of cells that are essentially untargeted. However both the variably targeted cells and neighboring bystander cells may respond to the treatment. Using ionizing radiation as an example of a targeted therapeutic agent, we describe a quantitative immunofluorescence-based approach for concomitant quantification of exposure and measurement of biological responses in both targeted and bystander cells. Cultures of human skin fibroblasts are co-pulse-labeled with 3H-deoxycytidine (3H-dC) and bromodeoxyuridine (BrdU). The labeled cells, identified by BrdU immunofluorescence, are internally irradiated by low-energy beta-particles emitted by incorporated 3H-dC. BrdU immunofluorescence intensity is proportional to radioactivity incorporated and, therefore, to radiation dose rate. Cell-cycle arrest in G2 is measured in labeled cells as function of dose rate. Stress responses in bystander cells, indicated by a G1 checkpoint, are concomitantly measured with a flow cytometric-cumulative labeling index (FCM-CLI) assay. The overall approach presented herein may be useful in the context of evaluating responses to targeted drug delivery.

Indexed as

Drug Delivery SystemsAntibody SpecificityBromodeoxyuridineBystander EffectCells, CulturedDNADNA ReplicationFibroblastsFlow CytometryG2 PhaseHumansIdoxuridineRadiation, IonizingRadiometryReproducibility of ResultsStaining and LabelingBromodeoxyuridineDNAIdoxuridine

Identifiers

PMID17695254
PMCPMC2939863
OpenAlexW2144370142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.